Before revision: Objectives NaV1.7 is a key target related to pain. This study focused on predicting and optimizing inhibitors of NaV1.7 using machine learning methods , and using patch-clamp methods to validate them at the cellular level.
After revision: We used machine learning methods , and using patch-clamp methods to validate them at the cellular level.